Thank you for sharing!

Your article was successfully shared with the contacts you provided.

The Supreme Court ruled in early March that federal law does not prevent people injured as a result of inadequate warnings on drug labels from suing the drug makers in state court, even if labels were approved by the Food & Drug Administration.

The 6-3 ruling by the court in Wyeth v. Levine is not the first case concerning state law preemption of medical products lawsuits decided by the Supreme Court in recent years. In February 2008, the court in an 8-1 decision ruled that state cases against medical device makers are preempted once their devices have been approved by the FDA.

Want to continue reading?
Become a Free
PropertyCasualty360 Digital Reader.


  • All PropertyCasualty360.com news coverage, best practices, and in-depth analysis.
  • Educational webcasts, resources from industry leaders, and informative newsletters.
  • Other award-winning websites including BenefitsPRO.com and ThinkAdvisor.com.

Already have an account?

Dig Deeper


Join PropertyCasualty360

Don’t miss crucial news and insights you need to make informed decisions for your P&C insurance business. Join PropertyCasualty360.com now!

  • Unlimited access to PropertyCasualty360.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including BenefitsPRO.com, ThinkAdvisor.com and Law.com
  • Exclusive discounts on PropertyCasualty360, National Underwriter, Claims and ALM events

Already have an account? Sign In Now
Join PropertyCasualty360

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.